ACTREC IEC Coordinator Recruitment 2025 - Walk-in

Advanced Centre for Treatment Research and Education in Cancer (ACTREC)
Posted:

Overview

ACTREC invites qualified candidates for the IEC Coordinator position on a contractual basis through a walk-in interview. Candidates with a PG in Science (M.Pharm/M.Sc) and a Diploma in Clinical Research and Pharmacovigilance, along with relevant experience, are encouraged to attend. The walk-in is scheduled for 06 January 2026 at ACTREC, Navi Mumbai.

Total Vacancies

TBA

Age Limit

TBA - 35y

Age Details

Age Details

Maximum Age: Up to 35 years. Age may be relaxed on the basis of experience at the discretion of management.

Eligibility

Eligibility Details

Essential qualifications

  • PG in Science (M.Pharm / M.Sc in Life Science / Clinical Research Regulatory Affairs) with at least 65% marks
  • Diploma in Clinical Research and Pharmacovigilance from a recognized university

Experience

  • Minimum of 1 year of experience in Clinical Research or IEC management is mandatory.

Important Dates

Application Start

TBA

Application End

TBA

Date Details

Important Dates

  • Advertisement Date: 16/12/2025
  • Walk-in Interview Date: 06/01/2026 (Tuesday)
  • Reporting Time: 10:00 a.m. to 10:30 a.m.

Note: Updated information was posted on 19 December 2025.

How to Apply

Other Instructions

  • The position is on an outsourced contract basis via ACTREC and Property Managers Pvt. Ltd. with an initial tenure of 6 months, extendable based on requirement.
  • Venue: 3rd Floor, Paymaster Shodhika, TMC-ACTREC, Sec-22, Kharghar, Navi Mumbai-410210.
  • Candidates must bring original and self-attested copies of all documents for verification during the interview, including qualification certificates and experience certificates.
  • Walk-in Interview Details: 06 January 2026, reporting between 10:00 a.m. and 10:30 a.m.

Frequently Asked Questions

Which body conducts the "ACTREC IEC Coordinator Recruitment 2025 - Walk-in"?

The "ACTREC IEC Coordinator Recruitment 2025 - Walk-in" is conducted by the Advanced Centre for Treatment Research and Education in Cancer (ACTREC).

Telegram